Official Title An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Glecaprevir-Pibrentasvir in Combination With Sofosbuvir and Ribavirin in Chronic Hepatitis C (HCV) Infected Subjects Who Have Experienced Virologic Failure in AbbVie HCV Clinical Studies (MAGELLAN-3).